Fundraising Fox

Therivabio

Rockville, US · 1 known investors

therivabio.com ↗

Theriva is a clinical-stage immuno-oncology company developing engineered oncolytic viruses designed for systemic administration and selective destruction of solid tumor cells. Its therapies target difficult-to-treat cancers and may be combined with existing standard-of-care cancer treatments.

BiotechHealthtechin /theriva-biologics@TOVXBiologics

Founders & leadership

SA
Steven A. ShallcrossExecutive Officer, Director
ST
Scott TarriffDirector
JS
Joseph SlimanExecutive Officer
JR
Jeffrey RileyExecutive Officer, Director
JJ
Jeffrey J. KrawsDirector
JA
Jeffrey A. WolfDirector
JM
John MonahanDirector

Investors · 1

Kinled HoldingHong Kongvia Patrick Aisher · inferred

Reported raises · per SEC filings

Form D private placements
▶$13.1MraisedOct 2025 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey J. KrawsDirector
  • Jeffrey A. WolfDirector
  • John MonahanDirector
  • Steven A. ShallcrossExecutive Officer, Director
Offering amount
$13.1M
Amount sold
$13.1M
Sales commissions
$308K
Placement agents
A.G.P./Alliance Global Partners
First sale
Oct 2025
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedAug 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey WolfDirector
  • Jeffrey J. KrawsDirector
  • John MonahanDirector
  • Steven A. ShallcrossExecutive Officer, Director
Offering amount
$3M
Amount sold
$3M
Minimum investment
$3M
Finders' fees
$175K
Placement agents
A.G.P./Alliance Global Partners
First sale
Jul 2022
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedMar 2022 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven A ShallcrossExecutive Officer, Director
  • Jeffrey J. KrawsDirector
  • John MonahanDirector
  • Jeffrey WolfDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Mar 2022
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedSep 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott TarriffDirector
  • Jeffrey KrawsDirector
  • Joseph SlimanExecutive Officer
  • Jeffrey WolfDirector
  • Steven ShallcrossExecutive Officer
  • Jeffrey RileyExecutive Officer, Director
Offering amount
$12M
Amount sold
$12M
Minimum investment
$12M
First sale
Sep 2017
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.